03 SEP 2010 05:51 CANCER CONTROL ACCRUAL REPORT
REGS. REGS. REGS. REGS. REGS.
LAST LAST LAST LAST LAST
TOTAL 12 6 3 30 7
STUDY REG. ARM REGS. Months Months Month DAYS DAYS ADMIN
----------------------------------------- ---- -------------------------------- ------ ------ ------ ------ ------ ------ ------
S8819-Lymphoma Immunophenotyping 1 1 Tissue Repository 456 9 4 2 1 0 LYMPH
**** ------ ------ ------
sum 456 1 0
S00002-SELECT Centralized Follow-up 1 5 Centralized Follow-up 12017 12017 9133 4661 1679 379 CC
**** ------ ------ ------
sum 12017 1679 379
S0000B-SELECT Eye Endpoints (SEE) 1 1 Registration 2436 84 0 0 0 0 CC
**** ------ ------ ------
sum 2436 0 0
S0000D-Adenoma Colorectal Polyps (ACP) 1 1 Registration 4667 1449 527 130 35 9 CC
**** ------ ------ ------
sum 4667 35 9
S0230-Breast,Adj,Chemo +/- Goserelin 1 1 Standard chemo 117 24 10 5 3 0 BREAST
2 Standard chemo + Goserelin 114 21 7 5 4 1 BREAST
**** ------ ------ ------
sum 231 7 1
S0421-Pros, Adv, Taxotere/Atrasentan 2 3 Continued Blinded drug 314 182 95 46 13 2 GU
**** ------ ------ ------
sum 314 13 2
S0424-Molecular Epidemiology NSCLC 1 1 Questionnaire & Specimen Sub 946 36 20 9 2 0 LUNG
**** ------ ------ ------
sum 946 2 0
S0622-Breast, Adv, 2 sched Dasatinib 1 1 Dasatinib, 100 mg daily 39 14 6 4 4 2 BREAST
2 Dasatinib, 70 mg bid 37 11 4 2 1 0 BREAST
**** ------ ------ ------
sum 76 5 2
S0702-Zoledronic Acid ONJ Registry 1 1 Observation for ONJ 568 454 264 137 58 9 CC
**** ------ ------ ------
sum 568 58 9
S0715-ALC Taxane-induced neuropathy 1 1 Blinded drug (ALC or Placebo) 125 125 90 49 21 7 CC
2 Blinded drug (ALC or Placebo) 120 120 86 46 19 5 CC
**** ------ ------ ------
sum 245 40 12
CANCER CONTROL ACCRUAL R
Open Studies with No Reg
------------------------
S0701A-1
SW
OG StatCtr Home Page